Robert H. Denlinger

Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design

Ping Wei, Marlena Walls, Ming Qiu et al. · Molecular Cancer Therapeutics · 2010 · 195 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.

James A. Swenberg, Adalbert Koestner, W. Wechsler et al. · PubMed · 1972 · 90 citations

Medicine, Oncology, Toxicology +12

Nonclinical Safety Evaluation of Sunitinib: A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET Receptors

Shem Patyna, Claudio Arrigoni, Andrea Terron et al. · Toxicologic Pathology · 2008 · 89 citations

Medicine, Oncology, Pharmacology +13

Differential Effect of Immunosuppression on the Induction of Nervous System and Bladder Tumors by N-Methyl N-Nitrosourea23

Robert H. Denlinger, James A. Swenberg, Adalbert Koestner et al. · JNCI Journal of the National Cancer Institute · 1973 · 41 citations

Medicine, Immunology, Oncology +6

Induction of neurogenic tumors in C3HeB/FeJ mice by nitrosourea derivatives: Observations by light microscopy, tissue culture, and electron microscopy

Robert H. Denlinger, A. Koestner, W. Wechsler · International Journal of Cancer · 1974 · 38 citations

Medicine, Neurobiology, Oncology +12